Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
US Army
Cantor Fitzgerald
Fish and Richardson
Harvard Business School

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022249

« Back to Dashboard

NDA 022249 describes TREANDA, which is a drug marketed by Cephalon and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and two Paragraph IV challenges. Additional details are available on the TREANDA profile page.

The generic ingredient in TREANDA is bendamustine hydrochloride. There are twenty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.
Summary for 022249
Ingredient:bendamustine hydrochloride
Formulation / Manufacturing:see details
Pharmacology for NDA: 022249
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for 022249
Suppliers and Packaging for NDA: 022249
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TREANDA bendamustine hydrochloride POWDER;IV (INFUSION) 022249 NDA Cephalon, Inc. 63459-390 N 63459-390-08
TREANDA bendamustine hydrochloride SOLUTION;IV (INFUSION) 022249 NDA Cephalon, Inc. 63459-390 N 63459-390-08

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength100MG/VIAL
Approval Date:Mar 20, 2008TE:APRLD:Yes
Patent:➤ Sign UpPatent Expiration:Apr 26, 2031Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Sep 26, 2029Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Jul 12, 2026Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.